Critical care nephrology · KIMS Secunderabad
Acute Tubular Necrosis — The Most Common Cause of Intrinsic Acute Kidney Injury
Acute tubular necrosis (ATN) is the most common cause of intrinsic acute kidney injury — AKI caused by direct damage to the kidney's tubular cells rather than by reduced blood flow (pre-renal AKI) or obstruction (post-renal AKI). The tubular cells of the proximal tubule and the thick ascending limb of the loop of Henle are the most metabolically active and the most vulnerable to ischaemic and toxic injury — their high energy demands make them the first to fail when oxygen or substrate delivery is compromised, and the first to be damaged by nephrotoxic substances.
ATN is common in hospitalised patients — it accounts for approximately 45% of all hospital-acquired AKI. It is a reversible condition in most cases: if the precipitating cause is corrected and the patient is supported through the oliguric phase (when the kidneys produce little or no urine), the tubular cells regenerate and kidney function recovers, typically over 1 to 3 weeks. In severe or prolonged cases, dialysis support (CRRT or intermittent HD at KIMS) bridges the patient through the recovery period. The mortality of ATN in the ICU setting remains high — 40 to 50% — reflecting the severity of the underlying conditions that precipitate it, not ATN itself.
Two categories of ATN
Ischaemic ATN
Caused by prolonged or severe reduction in renal blood flow — severe enough and prolonged enough to cause tubular cell death, beyond what pre-renal AKI (which is rapidly reversible with fluid resuscitation) alone causes. Common clinical scenarios: prolonged hypotension from septic shock, haemorrhagic shock, cardiogenic shock, or major surgery with intra-operative hypotension; prolonged cardiac surgery with cardiopulmonary bypass; aortic cross-clamping; renal artery occlusion; and severe haemoglobin or myoglobin release into the circulation (haemolysis, rhabdomyolysis) — which cause tubular injury both by reducing oxygen delivery and by direct haem-protein toxicity.
Nephrotoxic ATN
Caused by direct tubular cell toxicity from drugs, contrast agents, or endogenous substances. Common nephrotoxic causes: aminoglycoside antibiotics (gentamicin, amikacin — concentration in proximal tubular cells causes oxidative damage; predictable with total dose and trough monitoring), IV contrast agents (contrast nephropathy — covered in the dedicated KIMS Contrast Nephropathy page), NSAIDs in the context of reduced renal perfusion (reduce prostaglandin-mediated afferent arteriolar vasodilation — converting reversible pre-renal AKI to ATN), cisplatin chemotherapy, amphotericin B, and myoglobin from rhabdomyolysis.
Clinical course — three phases
Initiation phase · Hours to 1–2 days
The ischaemic or toxic insult occurs. Creatinine begins to rise. If the cause is corrected immediately at this stage, ATN may be prevented — the tubular injury has not yet become established.
Maintenance (oliguric) phase · 1–3 weeks (average 10–14 days)
Creatinine rises daily. Urine output is low (oliguria — below 400ml/day) or absent (anuria). Hyperkalaemia, metabolic acidosis, and fluid overload accumulate. Dialysis support (CRRT or IHD) may be required. The tubular cells are injured and not yet regenerating.
Recovery (diuretic) phase · 1–2 weeks
Tubular cells regenerate. Urine output increases dramatically — sometimes several litres per day (post-ATN diuresis). Creatinine begins to fall. Electrolytes (sodium, potassium) may fluctuate significantly as the recovering tubules have not yet regained full concentrating and reabsorptive function. Careful fluid and electrolyte management is essential.
Distinguishing ATN from pre-renal AKI — the key clinical decision
The distinction between pre-renal AKI (reduced perfusion — reversible with fluids) and established ATN (tubular damage — not immediately reversible with fluids) determines management:
Urine sodium: below 20 mEq/L in pre-renal AKI (the intact tubules conserve sodium avidly) · above 40 mEq/L in ATN (damaged tubules cannot conserve sodium).
Fractional excretion of sodium (FENa): below 1% in pre-renal · above 2% in ATN. FENa = (urine Na × plasma creatinine) ÷ (plasma Na × urine creatinine) × 100.
Urine osmolality: above 500 mOsm/kg in pre-renal (intact tubules concentrate urine) · below 350 mOsm/kg in ATN (damaged tubules cannot concentrate).
Urine sediment: bland (no casts) in pre-renal · muddy brown granular casts (shed tubular cells) pathognomonic of ATN.
Response to fluid challenge: creatinine improves with 500ml crystalloid over 30 minutes in pre-renal · does not improve in established ATN.
In patients on diuretics or with glycosuria (which artificially elevate FENa), the fractional excretion of urea (FEUrea) is a more reliable marker: below 35% suggests pre-renal; above 50% suggests ATN.
Treatment at KIMS
Remove or correct the precipitating cause
This is the most important intervention. Stop nephrotoxic drugs (aminoglycosides, NSAIDs, contrast — if ongoing). Treat sepsis. Correct hypotension with fluids and vasopressors. Treat rhabdomyolysis with aggressive hydration.
Avoid additional nephrotoxins
Once ATN is established, any further nephrotoxic exposure delays recovery. NSAIDs, aminoglycosides, contrast, and potassium-sparing diuretics are avoided.
Fluid management
Avoid fluid overload (which worsens pulmonary and outcomes) while maintaining mean arterial pressure above 65 mmHg. Goal-directed fluid therapy guided by clinical assessment.
CRRT (continuous renal replacement therapy)
For haemodynamically unstable patients with severe ATN, fluid overload, hyperkalaemia above 6.5 mEq/L, metabolic acidosis pH below 7.1, or uraemic complications (pericarditis, encephalopathy). CRRT available 24/7 at KIMS ICU.
Intermittent haemodialysis
For haemodynamically stable patients meeting dialysis thresholds.
Nutrition
Early enteral nutrition is important in ATN; uraemic patients are catabolic. High-protein feeding is not restricted in ATN patients who are on dialysis.
Book a Critical Care Nephrology Consultation at KIMS
Frequently Asked Questions — Acute Tubular Necrosis
No — approximately 50 to 60% of ATN patients recover without needing dialysis, provided the underlying cause is corrected promptly and fluid and electrolyte balance is managed carefully. Dialysis is required when: serum potassium rises above 6.5 mEq/L with ECG changes, metabolic acidosis falls below pH 7.1, fluid overload causes pulmonary oedema refractory to diuretics, or uraemic symptoms (encephalopathy, pericarditis) develop. The decision to initiate dialysis is clinical — no specific creatinine or urea threshold alone mandates dialysis. At KIMS, each ATN patient's daily clinical status determines whether dialysis support is required.
Yes — in the majority of cases. Tubular cells are capable of significant regeneration — the kidney has a remarkable capacity to recover from ischaemic and nephrotoxic injury if the precipitating cause is corrected. Complete recovery of kidney function to baseline occurs in approximately 50 to 70% of ATN patients. Partial recovery (improved kidney function but not back to full baseline) occurs in 20 to 30%. Permanent CKD from ATN occurs in 10 to 20% — particularly in patients with prolonged severe ATN, multiple ischaemic episodes, or ATN superimposed on pre-existing CKD. Each additional ATN episode in a patient with pre-existing CKD erodes further functional reserve.
Muddy brown granular casts — visible on urine microscopy under phase contrast — are the pathognomonic urine finding of ATN. They form when injured tubular cells slough off into the tubular lumen, combine with Tamm-Horsfall protein (a glycoprotein produced by the tubular cells), and form cylindrical casts moulded to the shape of the tubule. These casts are then washed into the urine. Their presence confirms intrinsic tubular injury and distinguishes ATN from pre-renal AKI (where the urine sediment is bland — no casts) and from glomerulonephritis (where red cell casts are found instead of granular casts).
Post-ATN (recovery phase) diuresis is the large increase in urine output — sometimes 3 to 5 litres per day — that occurs as the regenerating tubular cells restore filtration but before they have fully regained their reabsorptive capacity. The recovering tubules filter normally but cannot reabsorb water and electrolytes efficiently — producing large volumes of dilute urine. If this fluid loss is not replaced adequately, the patient develops hypovolaemia, hypokalaemia, hyponatraemia, and potentially circulatory collapse. Careful monitoring of urine output and electrolytes with appropriate replacement during the diuretic phase is essential — the recovery phase of ATN can be as dangerous as the oliguric phase if not managed carefully.
KIMS Secunderabad — Dr. E. Ravi (Senior Consultant Nephrologist, critical care nephrology lead), CRRT 24/7 in ICU, FENa and urine sediment assessment, goal-directed fluid management, aminoglycoside level monitoring, rhabdomyolysis protocol with aggressive hydration, post-ATN recovery monitoring. NABH and NABL accredited. Emergency line: 040-4488-5000.